WuXi Biologics (Cayman) I... (WXXWY)
OTC: WXXWY
· Real-Time Price · USD
10.85
0.18 (1.69%)
At close: Oct 03, 2025, 3:50 PM
10.70
-1.38%
Pre-market: Oct 03, 2025, 11:21 AM EDT
WuXi Biologics (Cayman) Balance Sheet Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 8.44B | 8.28B | 9.15B | 9.67B | 7.36B | 6.4B | 8.14B | 9B | 11.28B |
Short-Term Investments | 3.16B | 2.43B | 375.15M | 1.57B | 248.45M | 304.47M | 335.57M | 1.15B | 1.92B |
Long-Term Investments | 3.01B | -30.78M | 2.81B | 2.93B | 2.76B | 2.71B | 2.43B | 2.2B | 1.61B |
Other Long-Term Assets | 837.83M | 2.58B | 700.37M | 226.19M | -263.6M | -222.57M | -244.64M | -220.79M | -174.71M |
Receivables | 7.03B | 5.79B | 6.18B | 6.18B | 5.39B | 5.16B | 5.56B | 3.27B | 2.91B |
Inventory | 1.66B | 1.52B | 1.96B | 1.77B | 1.97B | 2.28B | 2.14B | 1.69B | 1.71B |
Other Current Assets | 3.22B | 5.47B | 2.05B | 2B | 1.82B | 2.32B | 3.09B | 3.44B | 3.42B |
Total Current Assets | 24.45B | 23.57B | 19.82B | 21.2B | 17.88B | 18.47B | 20.66B | 19.53B | 21.98B |
Property-Plant & Equipment | 30.18B | 28.44B | 30.78B | 29.94B | 28.99B | 25.92B | 21.85B | 19.76B | 17.74B |
Goodwill & Intangibles | 1.97B | 1.97B | 2B | 2.04B | 2.07B | 2.08B | 2.09B | 2.13B | 1.92B |
Total Long-Term Assets | 35.99B | 33.4B | 36.29B | 35.38B | 33.83B | 30.7B | 26.37B | 24.09B | 21.27B |
Total Assets | 60.44B | 56.98B | 56.11B | 56.58B | 52.14B | 49.56B | 47.47B | 44.03B | 43.58B |
Account Payables | 969.43M | 747.15M | 874.53M | 833.27M | 573.2M | 794.39M | 995.33M | 617.78M | 534.61M |
Deferred Revenue | n/a | n/a | n/a | n/a | -1.28B | -1.47B | -2.47B | -2.23B | -1.29B |
Short-Term Debt | 2.55B | 2.44B | 892.6M | 576.33M | 1.16B | 1.32B | 2.35B | 2.12B | 1.16B |
Other Current Liabilities | 3.72B | 2.58B | 3.93B | 5.27B | 5.37B | 6.06B | 5.07B | 4.56B | 3.17B |
Total Current Liabilities | 8.49B | 8.62B | 6.81B | 7.64B | 8.14B | 9.32B | 9B | 8.26B | 5.44B |
Long-Term Debt | 185.14M | 200.9M | 1.26B | 1.57B | 1.66B | 1.46B | 531.9M | 640.51M | 2.07B |
Other Long-Term Liabilities | 761.52M | n/a | 1.17B | n/a | -6.59B | -5.14B | -4.93B | -4.86B | -1.23B |
Total Long-Term Liabilities | 2.88B | 2.88B | 4.66B | 4.92B | 1.66B | 1.46B | 531.9M | 640.51M | 2.07B |
Total Liabilities | 11.37B | 11.5B | 11.46B | 12.56B | 13.1B | 13.35B | 11.99B | 11.33B | 10B |
Total Debt | 5.11B | 4.94B | 4.57B | 4.56B | 5.14B | 4.42B | 4.4B | 4.3B | 4.6B |
Book Value | 49.07B | 45.48B | 44.64B | 44.02B | 39.04B | 36.21B | 35.48B | 32.71B | 33.58B |
Book Value Per Share | 23.14 | 22.28 | 20.74 | 19.63 | 17.91 | 16.51 | 16.24 | 14.81 | 15.31 |
Common Stock | 223K | 226K | 228K | 235K | 234K | 233K | 235K | 235K | 234K |
Retained Earnings | n/a | 16.36B | n/a | 13.49B | 12.78B | 11.58B | 9.69B | 7.16B | 5.61B |
Comprehensive Income | 44.95B | n/a | 40.65B | 1.78B | 37.74B | 1.37B | 712.48M | 593.13M | 633.19M |
Shareholders Equity | 44.95B | 41.82B | 40.66B | 40.33B | 37.74B | 35.05B | 34.46B | 32.28B | 33.22B |
Total Investments | 6.16B | 2.4B | 3.15B | 3.27B | 3.01B | 3.01B | 2.77B | 3.35B | 3.53B |